Prolira is a medtech scale-up, offering an innovative vital sign monitor to hospitals. We commercially launched DeltaScan®, the world’s first EEG-based objective medical device to detect and monitor acute brain failure (acute encephalopathy / delirium). The DeltaScan® Brain State Monitor provides bedside EEG to improve medical decision support. We help hospital departments to increase quality of care and save costs at the same time. And for the US, we have identified a promising reimbursement opportunity. Prolira is a 13-person strong team, with passion, drive, and experience, and has already sold and delivered DeltaScan® products to over 20 hospitals in Europe. In the coming year, we intensify marketing and sales activities in key European countries and enter the US market.